Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 12;10(5):1177–1188. doi: 10.1111/jdi.13018

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

The effect of the administration of the studied peptides on the bodyweight of diabetes‐induced mice on day 1 (35.38 ± 0.27 g in all treatments), day 6 and day 12 of the experiment. 0, Non‐significant with the first day of the experiment; +, significant increase (P < 0.05); + +, very significant increase (P < 0.01); − , significant decrease (P < 0.05); − −, very significant decrease (P < 0.01; n = 10); CON, control group (only citrate buffer injection); DI, exposed to diabetes; DM, DI and 3% dimethyl sulfoxide as the solvent for the peptides (without a peptide); A, DM + Ala‐His (carnosine); B, DM + Glu‐Cys‐Gly (glutathione); C, DM + Leu‐Pro‐Pro; D, DM + Leu‐Gly; E, DM + Pro‐Gly‐Pro; F, DM + Pro‐Pro; G, DM + Pro‐Gly.